Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Free Cash Flow (2016 - 2026)

MedWellAI has reported Free Cash Flow over the past 12 years, most recently at -$84968.0 for Q4 2025.

  • Quarterly Free Cash Flow rose 61.19% to -$84968.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$642704.0 through Dec 2025, up 71.98% year-over-year, with the annual reading at -$850773.0 for FY2025, 79.39% up from the prior year.
  • Free Cash Flow was -$84968.0 for Q4 2025 at MedWellAI, up from -$170781.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $685233.0 in Q1 2022 and troughed at -$3.6 million in Q2 2023.
  • The 5-year median for Free Cash Flow is -$482459.5 (2022), against an average of -$756242.8.
  • The largest YoY upside for Free Cash Flow was 175.31% in 2022 against a maximum downside of 261965.98% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at -$39606.0 in 2021, then plummeted by 659.56% to -$300831.0 in 2022, then tumbled by 353.5% to -$1.4 million in 2023, then soared by 83.95% to -$218933.0 in 2024, then skyrocketed by 61.19% to -$84968.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Free Cash Flow are -$84968.0 (Q4 2025), -$170781.0 (Q3 2025), and -$108803.0 (Q2 2025).